Biological variation of PCA3 score in men previously diagnosed with prostate cancer

被引：3
|
作者：
Partin, Alan W.
Mangold, Leslie A.
Gurganus, Robin T.
Blase, Amy
Groskopf, Jack
Deras, Ina L.
Mathis, Jeanette
Carter, H. Ballentine
Rittenhouse, Harry
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)31811-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：538 / 538
页数：1
相关论文
共 50 条
  • [11] PCA3 urine assay for prostate cancer in Japanese men undergoing prostate biopsy
    Okihara, K.
    Ochial, A.
    Fros, Z.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [12] PCA3 SCORE CHANGE OVER TIME IN A PROSTATE CANCER SCREENING POPULATION
    Versluis, Yin
    Kranse, Ries
    Jenster, Guido
    Roobol, Monique
    JOURNAL OF UROLOGY, 2012, 187 (04): : E903 - E903
  • [13] Possibility of using PCA3 score without prostate massage in urine for diagnosing prostate cancer
    Musaelyan, A. A.
    Nazarov, V. D.
    Lapin, S., V
    Pavlova, O. N.
    Viktorov, D. A.
    Boriskin, A. G.
    Reva, S. A.
    Petrov, S. B.
    ONKOUROLOGIYA, 2020, 16 (04): : 82 - 88
  • [14] The use of PCA3 in the diagnosis of prostate cancer
    Hessels, Daphne
    Schalken, Jack A.
    NATURE REVIEWS UROLOGY, 2009, 6 (05) : 255 - 261
  • [15] The use of PCA3 in the diagnosis of prostate cancer
    Daphne Hessels
    Jack A. Schalken
    Nature Reviews Urology, 2009, 6 : 255 - 261
  • [16] The value of the PCA3 score in guiding prostate biopsy decision in men with a prior negative biopsy
    Haese, A.
    De La Taille, A.
    Van Poppel, H.
    Marberger, M.
    Stenzl, A.
    Mulders, P.
    Huland, H.
    Abbou, C. C.
    Joniau, S.
    Remzi, M.
    Tinzi, M.
    Feyerabend, S.
    Stillebroer, A.
    Van, Gils M.
    Schalken, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 142 - 142
  • [17] Progensa™ PCA3 test for prostate cancer
    Durand, Xavier
    Moutereau, Stephane
    Xylinas, Evanguelos
    de la Taille, Alexandre
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2011, 11 (02) : 137 - 144
  • [18] Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100)
    Roobol, Monique J.
    Schroder, Fritz H.
    van Leenders, Geert L. J. H.
    Hessels, Daphne
    van den Bergh, Roderick C. N.
    Wolters, Tineke
    van Leeuwen, Pim J.
    EUROPEAN UROLOGY, 2010, 58 (06) : 893 - 899
  • [19] PCA3 SCORE AND PROSTATE CANCER: IS 35 REALLY THE BEST CUT-OFF?
    De Luca, S.
    Randone, D. F.
    Bellei, L.
    Vestita, E.
    Volpe, A.
    Terrone, C.
    Bisconti, A.
    Fontana, D.
    Mari, M.
    Bellina, M.
    Borella, T.
    Chioso, P.
    Vottero, M.
    De Zan, A.
    Cucchiarale, G.
    Ferrando, U.
    Squintone, L.
    Carone, R.
    Lacquaniti, S.
    Fasolis, G.
    Cicilano, M.
    Milillo, A.
    Passera, R.
    ANTICANCER RESEARCH, 2010, 30 (04) : 1409 - 1409
  • [20] PROSTATE CANCER ANTIGEN 3 (PCA3) IS AN INDEPENDENT AND SIGNIFICANT PREDICTOR FOR PATHOLOGICALLY INSIGNIFICANT PROSTATE CANCER (PCA) IN MEN UNDERGOING RADICAL PROSTATECTOMY
    Ward, J. F.
    Chun, F.
    Graefen, M.
    Huland, H.
    Koellermann, J.
    Sauter, G.
    Babaian, R. J.
    Haese, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 293 - 293
12345